GPs unsure about breast cancer drugs

Doctors' concerns about efficacy and side effects continue to hamper the uptake of breast cancer-preventing drugs in primary care, an Australian study suggests.

Despite promising data from clinical trials, GPs still feel "uneducated and under-resourced" to prescribe risk-reducing drugs like tamoxifen, focus groups with Melbourne doctors revealed.

GPs cited concern about patient safety, questionable survival benefits and the lack of clear prescribing